JPH11510812A - 精製方法 - Google Patents
精製方法Info
- Publication number
- JPH11510812A JPH11510812A JP9508938A JP50893897A JPH11510812A JP H11510812 A JPH11510812 A JP H11510812A JP 9508938 A JP9508938 A JP 9508938A JP 50893897 A JP50893897 A JP 50893897A JP H11510812 A JPH11510812 A JP H11510812A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- salt
- vinyl
- compound
- aca
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000000746 purification Methods 0.000 title description 10
- 239000000203 mixture Substances 0.000 claims abstract description 61
- 150000003839 salts Chemical class 0.000 claims abstract description 33
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims description 61
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 239000002585 base Substances 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 125000000623 heterocyclic group Chemical group 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 claims description 10
- QIJIUJYANDSEKG-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-amine Chemical class CC(C)(C)CC(C)(C)N QIJIUJYANDSEKG-UHFFFAOYSA-N 0.000 claims description 9
- 238000002425 crystallisation Methods 0.000 claims description 9
- 230000008025 crystallization Effects 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 150000001768 cations Chemical class 0.000 claims description 6
- DLSOILHAKCBARI-UHFFFAOYSA-N n-benzyl-2-methylpropan-2-amine Chemical class CC(C)(C)NCC1=CC=CC=C1 DLSOILHAKCBARI-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 150000007529 inorganic bases Chemical group 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229930186147 Cephalosporin Natural products 0.000 claims description 4
- 150000001447 alkali salts Chemical group 0.000 claims description 4
- 229940124587 cephalosporin Drugs 0.000 claims description 4
- 150000001780 cephalosporins Chemical class 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 229910001389 inorganic alkali salt Inorganic materials 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- NVIAYEIXYQCDAN-CLZZGJSISA-N 7beta-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 claims 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 239000011877 solvent mixture Substances 0.000 claims 2
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- NVIAYEIXYQCDAN-MHTLYPKNSA-N (6r,7s)-7-azaniumyl-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound S1CC(C)=C(C([O-])=O)N2C(=O)[C@H]([NH3+])[C@@H]12 NVIAYEIXYQCDAN-MHTLYPKNSA-N 0.000 abstract description 65
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 43
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 25
- 238000004128 high performance liquid chromatography Methods 0.000 description 23
- 238000003756 stirring Methods 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000002244 precipitate Substances 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- -1 amine salts Chemical class 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- LTHNHFOGQMKPOV-UHFFFAOYSA-N 2-ethylhexan-1-amine Chemical class CCCCC(CC)CN LTHNHFOGQMKPOV-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 150000002576 ketones Chemical class 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- RTXOFQZKPXMALH-GHXIOONMSA-N cefdinir Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 RTXOFQZKPXMALH-GHXIOONMSA-N 0.000 description 4
- 229960003719 cefdinir Drugs 0.000 description 4
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 4
- 229960002129 cefixime Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000012296 anti-solvent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000002843 carboxylic acid group Chemical group 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N Cephalosporin C Natural products S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- KINULKKPVJYRON-PVNXHVEDSA-N n-[(e)-[10-[(e)-(4,5-dihydro-1h-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1h-imidazol-2-amine;hydron;dichloride Chemical compound Cl.Cl.N1CCN=C1N\N=C\C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1\C=N\NC1=NCCN1 KINULKKPVJYRON-PVNXHVEDSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- TXSYDJBJRNLGHB-UHFFFAOYSA-N sodium;2-trimethylsilylpropanoic acid Chemical class [Na].OC(=O)C(C)[Si](C)(C)C TXSYDJBJRNLGHB-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical class CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical class CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- NVIAYEIXYQCDAN-UHFFFAOYSA-N 7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)C(N)C12 NVIAYEIXYQCDAN-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 241000209027 Ilex aquifolium Species 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-O dicyclohexylazanium Chemical class C1CCCCC1[NH2+]C1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-O 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- MYRTYDVEIRVNKP-UHFFFAOYSA-N divinylbenzene Substances C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- RYRQCHXJLTVJJA-UHFFFAOYSA-N n-benzyl-n-ethenyl-2-methylpropan-2-amine Chemical class CC(C)(C)N(C=C)CC1=CC=CC=C1 RYRQCHXJLTVJJA-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical class CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical class [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical class CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 150000004023 quaternary phosphonium compounds Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- NFUHGQVNWQOHQB-UHFFFAOYSA-N sodium;trimethylsilyl propanoate Chemical class [Na].CCC(=O)O[Si](C)(C)C NFUHGQVNWQOHQB-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式(II): の7−ADCAおよび式 のビニル−ACAの混合物中の7−ADCAの減少方法。 2. a)式Iの化合物および式IIの化合物の塩の混合物を結晶化に付し、結 晶化された塩を単離しそして式Iの化合物に転化して式Iおよび式IIの化合物 の混合物よりも少ない式IIの化合物を含有するようにする、あるいは b)式Iの化合物および式IIの化合物の混合物をクロマトグラフィーに付す ことを特徴とする請求の範囲第1項に記載の方法。 3. 式Iの化合物および式IIの化合物の塩の混合物が式(III)および( IV): 〔ここで、X+はカチオンまたは式(V): (ここで、R1、R2およびR3は同じまたは異なりそして互いに独立して水素、 アルキル、アリール、アラルキルまたはシクロアルキルを表し,あるいはR1お よびR2は窒素原子と一緒になって複素環を形成し、そしてR3上記に定義された 通りである。) の化合物を表す。〕 の化合物の混合物である、請求の範囲第2項に記載の方法。 4. 式Iの化合物および式IIの化合物の塩の混合物が、塩 形成剤を溶媒中の請求の範囲第1項に定義された通りの式Iの化合物および請求 の範囲第1項に定義された通りの式IIの化合物の混合物に添加することにより 生成される、請求の範囲第2項に記載の方法。 5. 塩形成剤が、無機塩基、無機塩、有機塩または窒素塩基である、請求の範 囲第4項に記載の方法。 6. 無機塩基が水酸化物であり、無機塩が無機アルカリ塩であり、有機塩がカ ルボン酸のアルカリ塩であり、そして窒素塩基が式(VI): 〔ここで、R1、R2およびR3は請求の範囲第3項に定義された通りである。〕 の化合物である、請求の範囲第5項に記載の方法。 7. 結晶形態の式(III): 〔X+は請求の範囲第3項に定義された通りである。〕 の化合物。 8. 結晶形態の7−アミノ−3−ビニル−セファロスポラン酸のジシクロヘキ シルアンモニウム塩、 結晶形態の7−アミノ−3−ビニル−セファロスポラン酸のtert−オクチル アンモニウム塩、 結晶形態の7−アミノ−3−ビニル−セファロスポラン酸のN−ベンジル−te rt−ブチルアンモニウム塩、 結晶形態の7−アミノ−3−ビニル−セファロスポラン酸の2−エチル−1−ヘ キシルアンモニウム塩、又は 結晶形態の7−アミノ−3−ビニル−セファロスポラン酸のカリウム塩。 9. 高活性セファロスポリンの生成の際の、式(V): 〔ここで、X+は請求の範囲第3項に定義された通りである。〕 の化合物の使用または請求の範囲第1項に記載の方法の使用。 10. 式(I): のビニル−ACAと式(II): の7−ADCAとの混合物中の7−ADCAの減少方法において、 a)ビニル−ACAおよび7−ADCAの混合物を式(III)及び(IV): (ここで、R1’、R2’およびR3’は同じまたは異なりそして互いに独立して 水素、(C1 〜8)アルキル、置換された又は非置換のベンジルもしくはフェニル または(C4 〜8)シクロアルキルを表し、あるいはR1’およびR2’は窒素と一 緒になって5員または6員複素環を形成ししかも該複素環は更なる1個または2 個のヘテロ原子を含有し得、そしてR3’上記に定義された通りである。) のカチオンである。〕 の塩に、ビニル−ACAおよび7−ADCAの混合物とリチウム、ナトリウムも しくはカリウム塩基とのまたは式(VI’): 〔ここで、R1’、R2’およびR3’は上記に定義された通りである。〕 のアミンとの反応により転化し、しかも α)該反応を式IIIおよび式IVの塩が異なる溶解度を有す る溶媒または溶媒混合物中で行い、または β)式IIIおよび式IVの化合物の塩を溶媒または溶媒混合物中に懸濁させそ して溶解度積を調整し、 そして式IIIの化合物を単離した後、これを酸を用いて式Iの化合物に転化し て7−ADCAを含まないかまたは低減された7−ADCA含有率を有するよう にする、あるいは b)ビニル−ACAと7−ADCAとの混合物の溶液をクロマトグラフィーに付 す ことを特徴とする上記方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0136995A AT403049B (de) | 1995-08-14 | 1995-08-14 | Abreicherung von 7-adca in 3-vinyl-aca |
AT1369/95 | 1995-08-14 | ||
PCT/EP1996/003582 WO1997007121A1 (en) | 1995-08-14 | 1996-08-13 | Purification process |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003168797A Division JP2004043462A (ja) | 1995-08-14 | 2003-06-13 | 精製方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11510812A true JPH11510812A (ja) | 1999-09-21 |
JP3547141B2 JP3547141B2 (ja) | 2004-07-28 |
Family
ID=3512404
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50893897A Expired - Fee Related JP3547141B2 (ja) | 1995-08-14 | 1996-08-13 | 精製方法 |
JP2003168797A Pending JP2004043462A (ja) | 1995-08-14 | 2003-06-13 | 精製方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003168797A Pending JP2004043462A (ja) | 1995-08-14 | 2003-06-13 | 精製方法 |
Country Status (10)
Country | Link |
---|---|
US (4) | US6284888B1 (ja) |
EP (1) | EP0844999B1 (ja) |
JP (2) | JP3547141B2 (ja) |
AT (1) | AT403049B (ja) |
AU (1) | AU6821396A (ja) |
DE (1) | DE69627669T2 (ja) |
ES (1) | ES2198497T3 (ja) |
PT (1) | PT844999E (ja) |
TW (1) | TW530061B (ja) |
WO (1) | WO1997007121A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT403049B (de) * | 1995-08-14 | 1997-10-27 | Biochemie Gmbh | Abreicherung von 7-adca in 3-vinyl-aca |
AT405283B (de) * | 1997-04-04 | 1999-06-25 | Biochemie Gmbh | Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung |
AT404833B (de) * | 1997-06-04 | 1999-03-25 | Biochemie Gmbh | Verfahren zur isolierung der 7-aminocephalosporansäure (7-aca) |
AT404834B (de) * | 1997-06-30 | 1999-03-25 | Biochemie Gmbh | Verfahren zur isolierung der 7-aminocephalosporansäure (7-aca) |
AT406773B (de) | 1998-04-02 | 2000-08-25 | Biochemie Gmbh | Neues salz von 7-(2-(aminothiazol-4yl)-2- |
TW476040B (en) * | 1999-10-29 | 2002-02-11 | Toppan Printing Co Ltd | Method for distributing pay-information |
EP1842852A1 (en) | 2002-08-13 | 2007-10-10 | Sandoz AG | A cefdinir intermediate |
WO2007013043A2 (en) * | 2005-07-29 | 2007-02-01 | Ranbaxy Laboratories Limited | Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid |
CN110526928B (zh) * | 2019-09-17 | 2021-05-04 | 河北科技大学 | 一种7-氨基去乙酰氧基头孢烷酸的精制方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3894013A (en) | 1973-05-07 | 1975-07-08 | American Home Prod | Sulfin and sulfonamidino derivatives of cephalosporins. |
US4115646A (en) | 1975-02-22 | 1978-09-19 | Beecham Group Limited | Process for preparing 7-aminocephalosporanic acid derivatives |
US4091213A (en) | 1975-12-12 | 1978-05-23 | Bristol-Myers Company | 7-Cyclizedamino-3-heterothiomethyl cephalosporin derivatives |
AU2550077A (en) | 1976-06-14 | 1978-11-30 | Merck Patent Gmbh | Penicillins and cephalosporins |
US4409214A (en) | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
GB8323034D0 (en) | 1983-08-26 | 1983-09-28 | Fujisawo Pharmaceutical Co Ltd | 7-substituted-3-vinyl-3-cephem compounds |
US4754030A (en) | 1985-02-01 | 1988-06-28 | Bristol-Myers Company | Cefbuperazone crystalline triethylamine salt |
DE69231815T2 (de) * | 1991-03-08 | 2001-09-27 | Biochemie Ges.M.B.H., Kundl | Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren |
AT400436B (de) * | 1992-11-10 | 1995-12-27 | Biochemie Gmbh | Neues verfahren zur herstellung von 3-vinylcephalosporinverbindungen |
JP2825655B2 (ja) * | 1992-02-05 | 1998-11-18 | バイオケミ・ゲゼルシヤフト・エム・ベー・ハー | 3−セフェム−4−カルボン酸誘導体の精製方法 |
AT403049B (de) * | 1995-08-14 | 1997-10-27 | Biochemie Gmbh | Abreicherung von 7-adca in 3-vinyl-aca |
US5883247A (en) | 1996-06-10 | 1999-03-16 | Hoffmann-La Roche Inc. | Preparation of cephem and isooxacephem derivatives |
-
1995
- 1995-08-14 AT AT0136995A patent/AT403049B/de not_active IP Right Cessation
-
1996
- 1996-08-12 TW TW085109745A patent/TW530061B/zh not_active IP Right Cessation
- 1996-08-13 WO PCT/EP1996/003582 patent/WO1997007121A1/en active IP Right Grant
- 1996-08-13 JP JP50893897A patent/JP3547141B2/ja not_active Expired - Fee Related
- 1996-08-13 PT PT96928460T patent/PT844999E/pt unknown
- 1996-08-13 EP EP96928460A patent/EP0844999B1/en not_active Expired - Lifetime
- 1996-08-13 AU AU68213/96A patent/AU6821396A/en not_active Abandoned
- 1996-08-13 ES ES96928460T patent/ES2198497T3/es not_active Expired - Lifetime
- 1996-08-13 DE DE69627669T patent/DE69627669T2/de not_active Expired - Fee Related
-
2000
- 2000-05-09 US US09/567,623 patent/US6284888B1/en not_active Expired - Fee Related
-
2001
- 2001-05-25 US US09/865,914 patent/US20010037019A1/en not_active Abandoned
- 2001-06-13 US US09/880,213 patent/US20010044533A1/en not_active Abandoned
-
2003
- 2003-01-21 US US10/348,569 patent/US6835829B2/en not_active Expired - Fee Related
- 2003-06-13 JP JP2003168797A patent/JP2004043462A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US6284888B1 (en) | 2001-09-04 |
WO1997007121A1 (en) | 1997-02-27 |
JP3547141B2 (ja) | 2004-07-28 |
US20010037019A1 (en) | 2001-11-01 |
DE69627669D1 (de) | 2003-05-28 |
ES2198497T3 (es) | 2004-02-01 |
ATA136995A (de) | 1997-03-15 |
JP2004043462A (ja) | 2004-02-12 |
AU6821396A (en) | 1997-03-12 |
US20030153747A1 (en) | 2003-08-14 |
EP0844999A1 (en) | 1998-06-03 |
US6835829B2 (en) | 2004-12-28 |
EP0844999B1 (en) | 2003-04-23 |
PT844999E (pt) | 2003-07-31 |
AT403049B (de) | 1997-10-27 |
US20010044533A1 (en) | 2001-11-22 |
DE69627669T2 (de) | 2004-01-29 |
TW530061B (en) | 2003-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100442717B1 (ko) | 세프디니르의 결정성 아민 염 | |
US4252951A (en) | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid | |
JPH02177A (ja) | セファロスポリン系抗生物質の製造用中間体 | |
JPS5946954B2 (ja) | 抗生物質の製法 | |
JPH02311483A (ja) | セフトリアキソンの製造方法 | |
JP2825655B2 (ja) | 3−セフェム−4−カルボン酸誘導体の精製方法 | |
JPH11510812A (ja) | 精製方法 | |
JP2817563B2 (ja) | クラブラン酸塩の製造方法 | |
JPH07188250A (ja) | セファロスポリン異性体の分離 | |
US4898938A (en) | Method for preparing crystalline cefadroxil monohydrate | |
JP2000514090A (ja) | 精製方法 | |
JP2002510694A (ja) | セファロスポリン誘導体の精製方法 | |
US4003896A (en) | Method of preparing a sparingly soluble complex of cephalexin | |
US4902793A (en) | Process for preparing 3-alkoxymethylcephalosporins | |
JPS6118786A (ja) | セフタジダイムの改良結晶化法 | |
JPH10511377A (ja) | セフォタキシムの製造 | |
US3853863A (en) | Cephalosporin c isolation process | |
US4327211A (en) | Method for preparation of cephalosporin compounds | |
JPS6115885A (ja) | セフタジイムの製造 | |
US3843642A (en) | Cephalosporin c derivatives | |
CA1056814A (en) | Formyl-(p-acyloxyphenyl) acetamidocephalosporanic acid derivatives | |
JPS6031837B2 (ja) | セファロスポリンエステルの製造方法 | |
SU953983A3 (ru) | Способ получени производных цефалоспорина | |
JPH0665254A (ja) | セフォラニド誘導体 | |
FR2508458A1 (fr) | Nouveaux derives de l'acide cephalosporanique, leur preparation et leur application comme medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040305 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040330 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040413 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090423 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090423 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100423 Year of fee payment: 6 |
|
LAPS | Cancellation because of no payment of annual fees |